Related Experiment Video

Updated: Aug 8, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

Expression of a multidrug-resistance gene in human tumors and tissues

A T Fojo, K Ueda, D J Slamon

    Proceedings of the National Academy of Sciences of the United States of America
    |January 1, 1987
    PubMed

    Insights

    The human multidrug resistance gene (mdr1) is expressed in various normal tissues and human tumors. Measuring mdr1 RNA levels may aid in designing effective chemotherapy protocols.

    Area of Science:

    • Molecular Biology
    • Genetics
    • Oncology

    Background:

    • The human multidrug resistance gene (mdr1) plays a crucial role in cellular drug efflux.
    • Understanding mdr1 gene expression is vital for addressing multidrug resistance in cancer therapy.

    Purpose of the Study:

    • To investigate the expression patterns of the mdr1 gene in normal human tissues and various tumors.
    • To explore the potential of mdr1 RNA quantification as a biomarker for chemotherapy efficacy.

    Main Methods:

    • RNA extraction from human tumors and normal tissues.
    • Quantitative analysis of mdr1 RNA content using established molecular biology techniques.

    Main Results:

    • Significant mdr1 RNA expression was observed in the adrenal gland, kidney, lung, liver, jejunum, colon, and rectum.
    • mdr1 gene expression was detected in several human tumors, including adrenal and colon cancers.
    • Elevated mdr1 RNA levels were noted in some tumors post-chemotherapy relapse.

    Conclusions:

    • mdr1 gene expression varies across normal human tissues and is present in specific tumor types.
    • Quantifying mdr1 RNA may offer valuable insights for tailoring chemotherapy strategies.
    • Further clinical studies are warranted to validate mdr1 RNA as a predictive marker in cancer treatment.

    More Related Videos

    Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics12:28

    Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

    Published on: January 11, 2019

    Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System05:06

    Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

    Published on: January 5, 2024

    Related Concept Videos

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

    Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...